Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Immune function modulating agents

a technology of immune function and modulating agent, which is applied in the field of agents, can solve the problems of food allergy development, uninvestigated preventive and/or therapeutic effects of lactobacilli actually taken up by animals, and unfavorable evaluation of therapeutic effects against food allergies

Inactive Publication Date: 2016-04-19
MEIJI CO LTD
View PDF22 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0037]The agents of the present invention for preventing and / or treating allergies possess a resistance to a low pH environment and to bile acid, an IL-12 production-promoting activity, a Th1 / Th2 balance-improving effect, an ability to inhibit the production of IgE specific to food antigens in the serum, a Natural Killer cell-activating ability, and an eosinophilia-suppression ability, as confirmed in the Examples described below. Thus, the present invention enables the provision of novel agents for preventing and / or treating allergies, as well as dietary compositions including such agents for preventing and / or treating allergies, which are effective in preventing and / or treating various allergies such as food allergy.

Problems solved by technology

However, regarding Lactobacillus plantarum CCRC 12944 and Lactobacillus acidophilus CCRC 14079 described in Patent Document 1, although the ability of interferon γ-production from cultured cells was evaluated upon selection of the lactobacillus strains, the preventive and / or therapeutic effects for allergies when the lactobacilli are actually taken up by animals was not investigated.
Moreover, although it is desirable due to safety issues to isolate microorganism-based probiotics from humans (Non-Patent Document 3), this factor was not considered in the context of selection of the lactobacillus strains in the case of the lactobacillus strains described in Patent Documents 2 and 3 (Lactococcus lactis subsp.
However, it is unlikely that therapeutic effects against food allergies are appropriately evaluated by using the antibody production in systemic immunity as an index.
On the other hand, in some cases, it induces the production of IgE antibodies, thus leading to the development of food allergy.
The mechanism by which food, which normally should induce immune tolerance, induces food allergy is not sufficiently elucidated to date; however, it is contemplated that at least both the intestinal and systemic immune systems are involved in the development of food allergies.
Thus, it is unlikely that an evaluation of allergy-preventing effects using the systemic immune system reflects the therapeutic effects against food allergies.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Immune function modulating agents
  • Immune function modulating agents
  • Immune function modulating agents

Examples

Experimental program
Comparison scheme
Effect test

example 1

Gastric Acid Resistance Assay and Bile Acid Resistance Assay

[0071]273 lactobacillus strains of the Lactobacillus genus isolated from human feces were subjected to the following assays:

1) Gastric Acid Resistance Assay:

[0072]Lactobacillus bacteria were washed twice with physiological saline, and 1 ml of the lactobacillus suspension solution was added to 9 ml of filter sterilized artificial gastric fluid (NaCl (0.2%) and pepsin (1:5000, Tokyo Chemical Industry) (0.35%)) (pH 2). After aerobic culture at 37° C. for 2 hours, 1 ml was taken from this artificial gastric fluid containing the lactobacilli and added to 9 ml of phosphate buffer (67 mM, pH 6.5) to terminate the reaction. The number of live bacteria before and after contact with the artificial gastric fluid was measured using the Lactobacilli MRS Agar (Difco), and the viability rate (%) and gastric acid resistance (%) were calculated.

2) Bile Acid Resistance Assay:

[0073]10 μl of lactobacilli precultured twice (37° C., 18 hours) in...

example 2

Preparation of Freeze-dried lactobacillus Bacteria

[0077]The 20 lactobacillus strains of the Lactobacillus genus selected in Example 1 were precultured twice (37° C., 18 hours) in Lactobacilli MRS Broth. The precultures were inoculated in the sane medium at 1% and cultured at 37° C. for 18 hours. Bacteria were collected, then washed twice with physiological saline and once with sterile distilled water, sterilized by heating at 75° C. for 60 minutes, and freeze-dried. Freeze-dried bacterial powder was used in the in vitro assays and animal administration experiments below.

example 3

Assays for Evaluating the Effect of Promoting IL-12 Production from Mouse-derived Spleen Cells and the Th1 / Th2 Balance-improving Effect

[0078]The gastric acid-resistant and bile acid-resistant 20 lactobacillus strains of the Lactobacillus genus which were selected in Example 1 were evaluated by the methods below.

[0079]20 μg of ovalbumin (hereinafter also referred to as OVA, Wako Pure Chemical Industries) and 2 mg of aluminum hydroxide (Wako Pure Chemical Industries) were intraperitoneally administered to six-week-old male BALB / c mice (n=4, Japan SLC). Eight days later, the spleens were removed. Spleen cells from which erythrocytes have been removed were resuspended at 2.5×106 cells / ml in 10% FCS-RPMI 1640 medium (Gibco) containing 1 μg / ml of heat-treated lactobacilli prepared in Example 2 and 100 μg / ml of OVA, and cultured in a 5% CO2 incubator for six days. Type strains of the Lactobacillus genus (L. plantarum JCM 1149T, L. gasseri JCM 1131T, L. crispatus JCM 1185T, L. amylovorus JC...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
pHaaaaaaaaaa
Login to View More

Abstract

A probiotic lactobacillus was discovered from lactobacilli of the Lactobacillus genus independently isolated from human adult feces. The probiotic lactobacillus was selected from other bacterial strains for: (1) being highly resistant to gastric acid / bile acid; (2) having a high promoting activity on IL-12 production from mouse derived spleen cells and a high Th1 / Th2 balance-improving effect; (3) having a high ability to inhibit the production of antigen-specific IgE induced by intraperitoneally administering ovalbumin to BALB / c mice; (4) having a high ability to inhibit the production of antigen-specific IgE induced by orally administering a food antigen to C57BL / 6N mice; (5) having a high Natural Killer cell-activating ability; (6) having a high IL-12 production-promoting activity on spleen cells and mesenteric lymph node cells derived from mice immunized with ovalbumin and a high Th1 / Th2 balance-improving effect; and (7) having a high ability to suppress eosinophilia induced by a cedar pollen-extracted antigen. This discovery led to the completion of the present invention.

Description

[0001]This application is a National Stage Application of International Application Number PCT / JP2006 / 303295, filed Feb. 23, 2006; which claims priority to JP 2005-059460, filed Mar. 3, 2005.TECHNICAL FIELD[0002]The present invention relates to agents for preventing and / or treating allergies, as well as dietary compositions for preventing and / or treating allergies that include these agents.BACKGROUND ART[0003]A sharp increase in allergic disorders, such as bronchial asthma, allergic rhinitis, and atopic dermatitis, has been observed in the past decades, and current estimates suggest that at least about one fifth of the population is affected with some type of allergic disease. Since most of the current agents for treating allergies are symptomatic, and in view of the increase in the number of affected patients and the side effects that accompany long-term uses, more effective treatments have been desired (Non-Patent Document 1).[0004]Lactobacilli produce favorable flavoring substanc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(United States)
IPC IPC(8): C12N1/20A23C19/032A23C9/123A61K35/747A23C9/152A23L31/00A61K35/74A61P37/08C12R1/225
CPCA23C9/1234A23L1/3014A23C19/0323A61K35/747C12R1/225A23L33/135A61P37/02A61P37/08A61P43/00C12N1/205C12R2001/225A61K35/74
Inventor SASHIHARA, TOSHIHIROYAMAGUCHI, MAKOTONAKAMURA, YOSHITAKAIKEGAMI, SHUJINARUSHIMA, SEIKOKIMURA, KATSUNORINAGAFUCHI, SHINYATERAHARA, MASAKI
Owner MEIJI CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com